Source: Annual Congress 2011 - Epidemiology of lung cancer and screening



Rating:

Share or cite this content

Citations should be made in the following way:
P. Hatlen, B. H. Grønberg, A. Langhammer, S. M. Carlsen, T. Amundsen (Trondheim, Verdal, Norway). Increased survival in lung cancer patients with diabetes mellitus: A large cohort study. Eur Respir J 2011; 38: Suppl. 55, 2727

Member's Comments

No comment yet.

Related content which might interest you: Type 2 diabetes mellitus risk associated with sarcoidosis: A Swedish population-based cohort study Source: Virtual Congress 2020 – Sarcoidosis: from genetics to epidemiology Year: 2020 Prevalence and factors associated with diabetes mellitus among tuberculosis patients: a nationwide cohort Source: Eur Respir J 2016; 48: 264-268 Year: 2016 Does diabetes mellitus influence the prognosis of patients with lung cancer? Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013 Impact of diabetes mellitus on survival and hospitalization after lung transplantation Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Familial co-aggregation of asthma and type 1 diabetes mellitus in children– a Swedish population-based cohort study Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020 Prospective population-based study on the survival of patients with lung cancer Source: Eur Respir J 2002; 19: 1087-1092 Year: 2002 Comparison of COPD patients with and without diabetes mellitus Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 A study of the comorbidity of COPD and type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Relative risk of type 2 diabetes mellitus complications is increased in non effectively treated OSA patients Source: Eur Respir J 2005; 26: Suppl. 49, 39s Year: 2005 Relationship of hyperlipidemia to comorbidities and lung function in COPD: results of the COSYCONET cohort Source: International Congress 2017 – COPD: risk factors and prognosis Year: 2017 Nutrition-related factors associated with waiting list mortality in patients with interstitial lung disease: a retrospective cohort study Source: International Congress 2019 – Lung transplantation: from bench to bedside Year: 2019 Measurment of lung diffusion capacity in patients with diabetes mellitus Source: Annual Congress 2009 - Impact on respiratory function of pulmonary and extrapulmonary diseases Year: 2009 Cisplatin nephrotoxicity aggravated by cardiovascular disease and diabetes in lung cancer patients Source: Eur Respir J 2011; 37: 888-894 Year: 2011 Treatment effectiveness among patients with newly detected pulmonary tuberculosis with diabetes mellitus comorbidity Source: Eur Respir J 2004; 24: Suppl. 48, 653s Year: 2004 Impact on survival of history of diabetus mellitus in NSCLC patients Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Decline of the lung function and quality of glycemic control in type 2 diabetes mellitus Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013 Is lung a target organ in diabetes mellitus? Source: Eur Respir J 2002; 20: Suppl. 38, 491s Year: 2002 Is there any characteristics difference between pulmonary tuberculosis patients with and without diabetes mellitus type 2? Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities Year: 2009 Death rate of COPD patients and combination with type 2 diabetes Source: Eur Respir J 2007; 30: Suppl. 51, 79s Year: 2007